William T. Atchley

Role not yet determined Is this you? Add your title

UAMS

Also affiliated: University of North Carolina at Chapel Hill (2020); Pennsylvania State University (2014); United States Department of Veterans Affairs (2000); North Carolina State University (2000); University of Michigan (2000); University of Arkansas Medical Center (2021–2022); Michigan Medicine (2000); Ann Arbor VA Medical Center (2000)

8 h-index 17 pubs 456 cited

Research Areas

Biomedical Subjects

Links

Research Group UAMS TRI Profile

OverviewAI-generated summary

William T. Atchley's research has explored diverse areas including the development of monoclonal antibodies for treating methamphetamine addiction, the impact of selection for early growth on longevity in mice, and the association of tocilizumab with fungal infections in critically ill COVID-19 patients. He has also investigated pulmonary hypertension in chronic obstructive pulmonary disease and immune checkpoint inhibitor-related pneumonitis in lung cancer patients.

His work on methamphetamine addiction has involved developing high-affinity single-chain antibodies and assessing their effects on drug concentrations in pregnant rats. In studies concerning aging and longevity, Atchley has examined differential survival rates in genetically selected mouse stocks. His recent publications also touch upon infectious disease in the context of critical care and chronic respiratory conditions.

Metrics

h-index: 8
Publications: 17
Citations: 456

Selected Publications

A25-20 Therapeutic Plasma Exchange as Treatment for Iatrogenic Hyperviscosity Syndrome Induced by Intravenous Lipid Emulsions Infusion for Local Anesthetic Systemic Toxicity Syndrome (2026)

American Journal of Respiratory and Critical Care Medicine DOI OpenAlex
Navigating COPD in Aging Populations: Insights Into Pathophysiology and Comprehensive Care (2024)

Seminars in Respiratory and Critical Care Medicine 4 citations DOI OpenAlex
Vasoreactivity in Interstitial Lung Disease (ILD) Associated Pulmonary Hypertension - A Case of Robust Response to Inhaled Nitric Oxide (iNO) (2024)

DOI OpenAlex
Pulmonary hypertension in chronic obstructive pulmonary disease: current understanding, knowledge gaps and future directions (2023)

Current Opinion in Pulmonary Medicine 7 citations DOI OpenAlex
Tocilizumab Is Associated with Increased Risk of Fungal Infections among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study (2023)

Life 9 citations DOI OpenAlex
Ageing and chronic obstructive pulmonary disease: interrelationships (2023)

Current Opinion in Pulmonary Medicine 7 citations DOI OpenAlex
Response (2022)

CHEST Journal DOI OpenAlex
Tocilizumab is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study. (2021)

Research Square 5 citations DOI OpenAlex
Tocilizumab Is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19 (2021)

3 citations DOI OpenAlex
Immune Checkpoint Inhibitor-Related Pneumonitis in Lung Cancer (2021)

CHEST Journal 179 citations DOI OpenAlex
Treatment with a Monoclonal Antibody against Methamphetamine and Amphetamine Reduces Maternal and Fetal Rat Brain Concentrations in Late Pregnancy (2014)

Drug Metabolism and Disposition 14 citations DOI OpenAlex